Placulumab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Placulumab
Monoclonal antibody
Type?
SourceHuman
TargetTNF
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
KEGG
Chemical and physical data
FormulaC3404H5262N902O1036S22
Molar mass78.7 kg/mol g·mol−1

Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases.[1]

This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued.

References[edit]